Reducing recurrent stroke: Methodology of the motivational interviewing in stroke (MIST) randomized clinical trial

International Journal of Stroke

Volumn 9, Issue 1, 2014, Pages 133-139

  Krishnamurthi, Rita ^a   Witt, Emma ^a   Barker Collo, Suzanne ^b   Mcpherson, Kathryn ^a   Davis Martin, Kelly ^a,c   Bennett, Derrick ^d   Rush, Elaine ^a   Suh, Flora ^a   Starkey, Nicola ^e   Parag, Varsha ^b   Rathnasabapathy, Yogini ^f   Jones, Amy ^a   Brown, Paul ^g   Te Ao, Braden ^a   Feigin, Valery L ^a  

^a AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c HARVARD UNIVERSITY   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF WAIKATO   (New Zealand)

^f NORTH SHORE HOSPITAL   (New Zealand)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adherence; Motivational interviewing; Recurrent stroke; Secondary prevention

Indexed keywords

LOW DENSITY LIPOPROTEIN;

ADOLESCENT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MOTIVATIONAL INTERVIEWING; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SECONDARY PREVENTION; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE;

ADHERENCE; MOTIVATIONAL INTERVIEWING; RECURRENT STROKE; SECONDARY PREVENTION;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTIVATIONAL INTERVIEWING; PATIENT COMPLIANCE; RECURRENCE; RESEARCH DESIGN; SINGLE-BLIND METHOD; STROKE;

EID: 84890822043     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12107     Document Type: Article

References (58)

1. Talelli P, Greenwood RJ, Talelli P, Greenwood RJ. Recurrent stroke: where do we stand with the secondary prevention of noncardioembolic ischaemic strokes? Ther Adv Cardiovasc Dis [Review]. 2008; 2:387-405.
2. Hankey GJ, Hankey GJ. Secondary prevention of recurrent stroke. Stroke [Review]. 2005; 36:218-221.
3. Diener HC, Weimar C, Diener H-C, Weimar C. Update of secondary stroke prevention. Nephrol Dial Transplant [Editorial Research Support, N.I.H., Extramural Non-U.S. Gov't Review]. 2009; 24:1718-1724.
4. Pendlebury ST, Rothwell PM, Pendlebury ST, Rothwell PM. Risk of recurrent stroke, other vascular events and dementia after transient ischaemic attack and stroke. Cerebrovasc Dis [Research Support, Non-U.S. Gov't Review]. 2009; 27(Suppl. 3):1-11.
5. Boysen G, Truelsen T. Prevention of recurrent stroke. Neurol Sci [Review]. 2000; 21:67-72.
6. Hardie K, Hankey GJ, Jamrozik K, Broadhurst RJ, Anderson C. Ten-year risk of first recurrent stroke and disability after first-ever stroke in the Perth Community Stroke Study. Stroke 2004; 35:731-735.
7. Phillips RA, Phillips RA. A review of therapeutic strategies for risk reduction of recurrent stroke. Prog Cardiovasc Dis [Research Support, Non-U.S. Gov't Review]. 2008; 50:264-273.
8. Graham GD, Graham GD. Secondary stroke prevention: from guidelines to clinical practice. J Natl Med Assoc [Research Support, Non-U.S. Gov't Review]. 2008; 100:1125-1137.
9. Bushnell CD, Colon-Emeric CS, Bushnell CD, Colon-Emeric CS. Secondary stroke prevention strategies for the oldest patients: possibilities and challenges. Drugs Aging [Research Support, Non-U.S. Gov't Review]. 2009; 26:209-230.
10. Sacco RL, Adams R, Albers G etal. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation [Practice Guideline]. 2006; 113:e409-449.
11. Cuddy MLS. Treatment of hypertension: guidelines from JNC 7 (the seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 1). J Pract Nurs 2005; 55:17-21; quiz 2-3.
12. O'Donnell MJ, Xavier D, Liu L etal. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet [Multicenter Study Research Support, Non-U.S. Gov't]. 2010; 376:112-123.
13. Wolf PA, Clagett GP, Easton JD etal. Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: a statement for healthcare professionals from the stroke council of the American Heart Association. Stroke 1999; 30:1991-1994.
14. Cupples ME, McKnight A. Randomised controlled trial of health promotion in general practice for patients at high cardiovascular risk. BMJ [Clinical Trial Randomized Controlled Trial Research Support, Non-U.S. Gov't]. 1994; 309:993-996.
15. Smith J, Forster A, Young J, Cochrane Group for information provision after s. Cochrane review: information provision for stroke patients and their caregivers. Clin Rehabil [Research Support, Non-U.S. Gov't Review]. 2009; 23:195-206.
16. Campbell NC, Thain J, Deans HG, Ritchie LD, Rawles JM, Squair JL. Secondary prevention clinics for coronary heart disease: randomised trial of effect on health. BMJ [Clinical Trial Randomized Controlled Trial Research Support, Non-U.S. Gov't]. 1998; 316:1434-1437.
17. Delaney EK, Murchie P, Lee AJ, Ritchie LD, Campbell NC. Secondary prevention clinics for coronary heart disease: a 10-year follow-up of a randomised controlled trial in primary care. Heart [Evaluation Studies Multicenter Study]. 2008; 94:1419-1423.
18. Jolly K, Bradley F, Sharp S etal. Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton heart integrated care project (SHIP). The SHIP Collaborative Group. BMJ [Clinical Trial Randomized Controlled Trial Research Support, Non-U.S. Gov't]. 1999; 318:706-711.
19. Ellis G, Rodger J, McAlpine C etal. The impact of stroke nurse specialist input on risk factor modification: a randomised controlled trial. Age Ageing [Clinical Trial Randomized Controlled Trial Research Support, Non-U.S. Gov't]. 2005; 34:389-392.
20. Redfern J, Rudd AD, Wolfe CD etal. Stop Stroke: development of an innovative intervention to improve risk factor management after stroke. Patient Educ Couns [Evaluation Studies Research Support, Non-U.S. Gov't]. 2008; 72:201-209.
21. Ovbiagele B, Saver JL, Fredieu A etal. PROTECT: a coordinated stroke treatment program to prevent recurrent thromboembolic events. Neurology [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. 2004; 63:1217-1222.
22. LaBresh KA, Ellrodt AG, Gliklich R etal. Get with the guidelines for cardiovascular secondary prevention: pilot results. Arch Intern Med [Research Support, Non-U.S. Gov't]. 2004; 164:203-209.
23. Lawrence M, Kerr S, McVey C, Godwin J. The effectiveness of secondary prevention lifestyle interventions designed to change lifestyle behavior following stroke: summary of a systematic review. Int J Stroke [Research Support, Non-U.S. Gov't Review]. 2012; 7:243-247.
24. Ovbiagele B, Campbell S, Faiz A, Chambless LE, Investigators VS. Relationship between non-specific prescription pill adherence and ischemic stroke outcomes. Cerebrovasc Dis [Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural]. 2010 Jan;29:146-153.
25. Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc 2011; 86:304-314.
26. Sabaté E (ed.). Adherence to Long-Term Therapies: Evidence for Action. Geneva, Switzerland, World Health Organization, 2003.
27. Group NZG. Life after Stroke. New Zealand Guideline for Management of Stroke. Wellington, Stroke Foundation New Zealand Inc., 2003.
28. Aspegren K, Risager NE, Stromming M. Learning 'The Motivational Interview' in a simple way. Ugeskr Laeger 2008; 170:39-43.
29. Castro MMLD, Passos SRL. Motivational interview and scales used to assess the degree of motivation for treatment in drug abuse patients. Rev Psiquiatr Clín 2005; 32:330-335.
30. Florez-Alarcon L, Carranza WA. The motivational interview as a tool for encouraging lifestyle changes in people with chronic non transmittable diseases. Av Piscol Clin Latinonot 2007; 25:63-82.
31. Lussier MT, Richard C. The motivational interview: in practice. Can Fam Physician 2007; 53:2117-2118.
32. Miller RW, Rollnick S. Motivational Interviewing: Preparing People to Change Addictive Behavior. New York, NY, The Guilford Press, 1991.
33. Rollnick S, Mason P, Butler C. Health Behavior Change: A Guide for Practitioners. New York, NY, Churchill Livingstone, 2000.
34. Heather N. Motivational interviewing: effectiveness and cost-effectiveness. Addiction 2001; 96:1772-1773.
35. Stein LAR, Lebeau R, Colby SM, Barnett NP, Golembeske C, Monti PM. Motivational interviewing for incarcerated adolescents: effects of depressive symptoms on reducing alcohol and marijuana use after release. J Stud Alcohol [Comparative Study Randomized Controlled Trial Research Support, N.I.H., Extramural]. 2011; 72:497-506.
36. Smith AJ, Shepherd JP, Hodgson RJ. Brief interventions for patients with alcohol-related trauma. Br J Oral Maxillofac Surg [Research Support, Non-U.S. Gov't Review]. 1998; 36:408-415.
37. Baker A, Lewin T, Reichler H etal. Evaluation of a motivational interview for substance use within psychiatric in-patient services. Addiction [Clinical Trial Randomized Controlled Trial Research Support, Non-U.S. Gov't]. 2002; 97:1329-1337.
38. Murphy JG, Benson TA, Vuchinich RE etal. A comparison of personalized feedback for college student drinkers delivered with and without a motivational interview. J Stud Alcohol [Clinical Trial Comparative Study Randomized Controlled Trial Research Support, U.S. Gov't, Non-P.H.S.]. 2004; 65:200-203.
39. Lussier MT, Richard C, Lussier M-T, Richard C. The motivational interview: in practice. Can Fam Physician 2007; 53:2117-2118.
40. Rivera Mercado S, Villouta Cassinelli MF, Ilabaca Grez A, Rivera Mercado S, Villouta Cassinelli MF, Ilabaca Grez A. [Motivational interviews: what are their effectiveness in prevalent primary care problems?]. Aten Primaria 2008; 40:257-261.
41. Dunn C, DeRoo L, Rivara FP. The use of brief interventions adapted from motivational interviewing across behavioral domains: a systematic review. Addiction 2001; 96:1725-1742.
42. Miller WR, Rollnick S. Motivational Interviewing: Preparing People for Change, 2nd edn. New York, Guilford Press, 2002.
43. Watkins CL, Auton MF, Deans CF etal. Motivational interviewing early after acute stroke: a randomized, controlled trial. Stroke [Comparative Study Randomized Controlled Trial Research Support, Non-U.S. Gov't]. 2007; 38:1004-1009.
44. Leathley MJ, Fall S, Sharma AK, Watkins C, Barer D. Life after stroke [abstract]: multi-centre trial of psychosocial interventions after stroke. Cerebrovasc Dis 2003; 16(Suppl. 4):70.
45. Lincoln NB, Flannaghan T. Cognitive behavioral psychotherapy for depression following stroke: a randomized controlled trial. Stroke [Clinical Trial Randomized Controlled Trial Research Support, Non-U.S. Gov't]. 2003; 34:111-115.
46. Dennis M, O'Rourke S, Slattery J, Staniforth T, Warlow C. Evaluation of a stroke family care worker: results of a randomised controlled trial. BMJ [Clinical Trial Randomized Controlled Trial]. 1997; 314:1071-1076. discussion 6-7.
47. Forster A, Young J. Specialist nurse support for patients with stroke in the community: a randomised controlled trial. BMJ 1996; 312:1642-1646.
48. Bombardier CH, Bell KR, Temkin NR etal. The efficacy of a scheduled telephone intervention for ameliorating depressive symptoms during the first year after traumatic brain injury. J Head Trauma Rehabil [Randomized Controlled Trial Research Support, Non-U.S. Gov't]. 2009; 24:230-238.
49. Woollard J, Beilin L, Lord T, Puddey I, MacAdam D, Rouse I. A controlled trial of nurse counselling on lifestyle change for hypertensives treated in general practice: preliminary results. Clin Exp Pharmacol Physiol [Clinical Trial Randomized Controlled Trial Research Support, Non-U.S. Gov't]. 1995; 22:466-468.
50. Reid CM, Murphy B, Murphy M, Maher T, Ruth D, Jennings G. Prescribing medication versus promoting behavioural change: a trial of the use of lifestyle management to replace drug treatment of hypertension in general practice. Behav Change 1994; 11:177-185.
51. Groeneveld IF, Proper KI, Van Der Beek AJ, Van Duivenbooden C, Van Mechelen W. Design of a RCT evaluating the (cost-) effectiveness of a lifestyle intervention for male construction workers at risk for cardiovascular disease: the health under construction study. BMC Public Health 2008; 8:1. doi: 10.1186/1471-2458-8-1.
52. Longabaugh R. Comments on Dunn etal.'s 'The use of brief interventions adapted from motivational interviews across behavioral domains: a systematic review'. Why is motivational interviewing effective? Addiction [Comment]. 2001; 96:1773-1774. discussion 4-5.
53. Krishnamurthi R, Jones A, Barber A etal. Methodology of a population-based stroke and TIA incidence and outcomes study: the Auckland Regional Community Stroke Study (ARCOS IV) 2011-2012. Int J Stroke 2013; DOI: 10.1111/ijs.12108.
54. Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ 1980; 58:113-130.
55. Sterne JAC, White IR, Carlin JB etal. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ [Research Support, Non-U.S. Gov't]. 2009; 338:b2393.
56. Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A Users Manual. Boston, The Health Institute, New England Medical Centre, 1994.
57. Johnston M, Pollard B, Hennessey P. Construct validation of the hospital anxiety and depression scale with clinical populations. J Psychosom Res 2000; 48:579-584.
58. Sulter G, Steen C, De KJ. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke 1999; 30:1538-1541.